- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Unlike with generic drugs of the more common small-molecule type, biologics generally exhibit high molecular complexity and may be quite sensitive to changes in manufacturing processes. Despite that heterogeneity, all biopharmaceuticals, including biosimilar, must maintain consistent quality and clinical performance throughout their lifecycle.
In this report is a biologic defined as proteins, peptides, hormones or antibody’s drugs production by bio-engineered technology, but does not include a vaccine.
According to our latest study, the global Biosimilar market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China’s core biosimilar players include Qilu Pharmaceutical, Shanghai Henlius and 3SBIO etc. The top 3 companies only hold a share about 61%.
In terms of product, biosimilar monoclonal antibodies is the largest segment, with a share about 85%. And in terms of application, the largest application is cancer，with a share about 50%.
This report is a detailed and comprehensive analysis for global Biosimilar market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biosimilar market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biosimilar market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biosimilar market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biosimilar market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilar
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilar market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius and Innovent Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biosimilar market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biosimilar Monoclonal Antibodies
Biosimilar Insulin
Others
Market segment by Application
Cancer
Immunological Diseases
Diabetes
Others
Market segment by players, this report covers
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar, with revenue, gross margin and global market share of Biosimilar from 2018 to 2023.
Chapter 3, the Biosimilar competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biosimilar market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar.
Chapter 13, to describe Biosimilar research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar by Type
1.3.1 Overview: Global Biosimilar Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biosimilar Consumption Value Market Share by Type in 2022
1.3.3 Biosimilar Monoclonal Antibodies
1.3.4 Biosimilar Insulin
1.3.5 Others
1.4 Global Biosimilar Market by Application
1.4.1 Overview: Global Biosimilar Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer
1.4.3 Immunological Diseases
1.4.4 Diabetes
1.4.5 Others
1.5 Global Biosimilar Market Size & Forecast
1.6 Global Biosimilar Market Size and Forecast by Region
1.6.1 Global Biosimilar Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biosimilar Market Size by Region, (2018-2029)
1.6.3 North America Biosimilar Market Size and Prospect (2018-2029)
1.6.4 Europe Biosimilar Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biosimilar Market Size and Prospect (2018-2029)
1.6.6 South America Biosimilar Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biosimilar Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Qilu Pharmaceutical
2.1.1 Qilu Pharmaceutical Details
2.1.2 Qilu Pharmaceutical Major Business
2.1.3 Qilu Pharmaceutical Biosimilar Product and Solutions
2.1.4 Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.2 Bio-Thera
2.2.1 Bio-Thera Details
2.2.2 Bio-Thera Major Business
2.2.3 Bio-Thera Biosimilar Product and Solutions
2.2.4 Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Thera Recent Developments and Future Plans
2.3 Zhejiang Hisun
2.3.1 Zhejiang Hisun Details
2.3.2 Zhejiang Hisun Major Business
2.3.3 Zhejiang Hisun Biosimilar Product and Solutions
2.3.4 Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zhejiang Hisun Recent Developments and Future Plans
2.4 Shanghai Henlius
2.4.1 Shanghai Henlius Details
2.4.2 Shanghai Henlius Major Business
2.4.3 Shanghai Henlius Biosimilar Product and Solutions
2.4.4 Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shanghai Henlius Recent Developments and Future Plans
2.5 Innovent Biologics
2.5.1 Innovent Biologics Details
2.5.2 Innovent Biologics Major Business
2.5.3 Innovent Biologics Biosimilar Product and Solutions
2.5.4 Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Innovent Biologics Recent Developments and Future Plans
2.6 Jiangsu Hengrui
2.6.1 Jiangsu Hengrui Details
2.6.2 Jiangsu Hengrui Major Business
2.6.3 Jiangsu Hengrui Biosimilar Product and Solutions
2.6.4 Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jiangsu Hengrui Recent Developments and Future Plans
2.7 Gan&Lee
2.7.1 Gan&Lee Details
2.7.2 Gan&Lee Major Business
2.7.3 Gan&Lee Biosimilar Product and Solutions
2.7.4 Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Gan&Lee Recent Developments and Future Plans
2.8 Tonghua Dongbao
2.8.1 Tonghua Dongbao Details
2.8.2 Tonghua Dongbao Major Business
2.8.3 Tonghua Dongbao Biosimilar Product and Solutions
2.8.4 Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Tonghua Dongbao Recent Developments and Future Plans
2.9 United Laboratory
2.9.1 United Laboratory Details
2.9.2 United Laboratory Major Business
2.9.3 United Laboratory Biosimilar Product and Solutions
2.9.4 United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 United Laboratory Recent Developments and Future Plans
2.10 3SBIO
2.10.1 3SBIO Details
2.10.2 3SBIO Major Business
2.10.3 3SBIO Biosimilar Product and Solutions
2.10.4 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 3SBIO Recent Developments and Future Plans
2.11 Luye Pharma
2.11.1 Luye Pharma Details
2.11.2 Luye Pharma Major Business
2.11.3 Luye Pharma Biosimilar Product and Solutions
2.11.4 Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Luye Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biosimilar Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biosimilar by Company Revenue
3.2.2 Top 3 Biosimilar Players Market Share in 2022
3.2.3 Top 6 Biosimilar Players Market Share in 2022
3.3 Biosimilar Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Market: Region Footprint
3.3.2 Biosimilar Market: Company Product Type Footprint
3.3.3 Biosimilar Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Biosimilar Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biosimilar Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Biosimilar Consumption Value Market Share by Application (2018-2023)
5.2 Global Biosimilar Market Forecast by Application (2024-2029)
6 North America
6.1 North America Biosimilar Consumption Value by Type (2018-2029)
6.2 North America Biosimilar Consumption Value by Application (2018-2029)
6.3 North America Biosimilar Market Size by Country
6.3.1 North America Biosimilar Consumption Value by Country (2018-2029)
6.3.2 United States Biosimilar Market Size and Forecast (2018-2029)
6.3.3 Canada Biosimilar Market Size and Forecast (2018-2029)
6.3.4 Mexico Biosimilar Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Biosimilar Consumption Value by Type (2018-2029)
7.2 Europe Biosimilar Consumption Value by Application (2018-2029)
7.3 Europe Biosimilar Market Size by Country
7.3.1 Europe Biosimilar Consumption Value by Country (2018-2029)
7.3.2 Germany Biosimilar Market Size and Forecast (2018-2029)
7.3.3 France Biosimilar Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biosimilar Market Size and Forecast (2018-2029)
7.3.5 Russia Biosimilar Market Size and Forecast (2018-2029)
7.3.6 Italy Biosimilar Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biosimilar Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biosimilar Market Size by Region
8.3.1 Asia-Pacific Biosimilar Consumption Value by Region (2018-2029)
8.3.2 China Biosimilar Market Size and Forecast (2018-2029)
8.3.3 Japan Biosimilar Market Size and Forecast (2018-2029)
8.3.4 South Korea Biosimilar Market Size and Forecast (2018-2029)
8.3.5 India Biosimilar Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biosimilar Market Size and Forecast (2018-2029)
8.3.7 Australia Biosimilar Market Size and Forecast (2018-2029)
9 South America
9.1 South America Biosimilar Consumption Value by Type (2018-2029)
9.2 South America Biosimilar Consumption Value by Application (2018-2029)
9.3 South America Biosimilar Market Size by Country
9.3.1 South America Biosimilar Consumption Value by Country (2018-2029)
9.3.2 Brazil Biosimilar Market Size and Forecast (2018-2029)
9.3.3 Argentina Biosimilar Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biosimilar Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biosimilar Market Size by Country
10.3.1 Middle East & Africa Biosimilar Consumption Value by Country (2018-2029)
10.3.2 Turkey Biosimilar Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biosimilar Market Size and Forecast (2018-2029)
10.3.4 UAE Biosimilar Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Biosimilar Market Drivers
11.2 Biosimilar Market Restraints
11.3 Biosimilar Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Biosimilar Industry Chain
12.2 Biosimilar Upstream Analysis
12.3 Biosimilar Midstream Analysis
12.4 Biosimilar Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 6. Qilu Pharmaceutical Major Business
Table 7. Qilu Pharmaceutical Biosimilar Product and Solutions
Table 8. Qilu Pharmaceutical Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Qilu Pharmaceutical Recent Developments and Future Plans
Table 10. Bio-Thera Company Information, Head Office, and Major Competitors
Table 11. Bio-Thera Major Business
Table 12. Bio-Thera Biosimilar Product and Solutions
Table 13. Bio-Thera Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Thera Recent Developments and Future Plans
Table 15. Zhejiang Hisun Company Information, Head Office, and Major Competitors
Table 16. Zhejiang Hisun Major Business
Table 17. Zhejiang Hisun Biosimilar Product and Solutions
Table 18. Zhejiang Hisun Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Zhejiang Hisun Recent Developments and Future Plans
Table 20. Shanghai Henlius Company Information, Head Office, and Major Competitors
Table 21. Shanghai Henlius Major Business
Table 22. Shanghai Henlius Biosimilar Product and Solutions
Table 23. Shanghai Henlius Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Shanghai Henlius Recent Developments and Future Plans
Table 25. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 26. Innovent Biologics Major Business
Table 27. Innovent Biologics Biosimilar Product and Solutions
Table 28. Innovent Biologics Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Innovent Biologics Recent Developments and Future Plans
Table 30. Jiangsu Hengrui Company Information, Head Office, and Major Competitors
Table 31. Jiangsu Hengrui Major Business
Table 32. Jiangsu Hengrui Biosimilar Product and Solutions
Table 33. Jiangsu Hengrui Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Jiangsu Hengrui Recent Developments and Future Plans
Table 35. Gan&Lee Company Information, Head Office, and Major Competitors
Table 36. Gan&Lee Major Business
Table 37. Gan&Lee Biosimilar Product and Solutions
Table 38. Gan&Lee Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Gan&Lee Recent Developments and Future Plans
Table 40. Tonghua Dongbao Company Information, Head Office, and Major Competitors
Table 41. Tonghua Dongbao Major Business
Table 42. Tonghua Dongbao Biosimilar Product and Solutions
Table 43. Tonghua Dongbao Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Tonghua Dongbao Recent Developments and Future Plans
Table 45. United Laboratory Company Information, Head Office, and Major Competitors
Table 46. United Laboratory Major Business
Table 47. United Laboratory Biosimilar Product and Solutions
Table 48. United Laboratory Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. United Laboratory Recent Developments and Future Plans
Table 50. 3SBIO Company Information, Head Office, and Major Competitors
Table 51. 3SBIO Major Business
Table 52. 3SBIO Biosimilar Product and Solutions
Table 53. 3SBIO Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. 3SBIO Recent Developments and Future Plans
Table 55. Luye Pharma Company Information, Head Office, and Major Competitors
Table 56. Luye Pharma Major Business
Table 57. Luye Pharma Biosimilar Product and Solutions
Table 58. Luye Pharma Biosimilar Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Luye Pharma Recent Developments and Future Plans
Table 60. Global Biosimilar Revenue (USD Million) by Players (2018-2023)
Table 61. Global Biosimilar Revenue Share by Players (2018-2023)
Table 62. Breakdown of Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Biosimilar Players
Table 65. Biosimilar Market: Company Product Type Footprint
Table 66. Biosimilar Market: Company Product Application Footprint
Table 67. Biosimilar New Market Entrants and Barriers to Market Entry
Table 68. Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Biosimilar Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Biosimilar Consumption Value Share by Type (2018-2023)
Table 71. Global Biosimilar Consumption Value Forecast by Type (2024-2029)
Table 72. Global Biosimilar Consumption Value by Application (2018-2023)
Table 73. Global Biosimilar Consumption Value Forecast by Application (2024-2029)
Table 74. North America Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Biosimilar Raw Material
Table 105. Key Suppliers of Biosimilar Raw Materials
List of Figures
Figure 1. Biosimilar Picture
Figure 2. Global Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biosimilar Consumption Value Market Share by Type in 2022
Figure 4. Biosimilar Monoclonal Antibodies
Figure 5. Biosimilar Insulin
Figure 6. Others
Figure 7. Global Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Biosimilar Consumption Value Market Share by Application in 2022
Figure 9. Cancer Picture
Figure 10. Immunological Diseases Picture
Figure 11. Diabetes Picture
Figure 12. Others Picture
Figure 13. Global Biosimilar Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Biosimilar Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Biosimilar Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Biosimilar Consumption Value Market Share by Region in 2022
Figure 18. North America Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Biosimilar Revenue Share by Players in 2022
Figure 24. Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Biosimilar Market Share in 2022
Figure 26. Global Top 6 Players Biosimilar Market Share in 2022
Figure 27. Global Biosimilar Consumption Value Share by Type (2018-2023)
Figure 28. Global Biosimilar Market Share Forecast by Type (2024-2029)
Figure 29. Global Biosimilar Consumption Value Share by Application (2018-2023)
Figure 30. Global Biosimilar Market Share Forecast by Application (2024-2029)
Figure 31. North America Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 41. France Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 48. China Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 51. India Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 65. Biosimilar Market Drivers
Figure 66. Biosimilar Market Restraints
Figure 67. Biosimilar Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Biosimilar in 2022
Figure 70. Manufacturing Process Analysis of Biosimilar
Figure 71. Biosimilar Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
